Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ambrx Biopharma Inc. | Director | Ordinary Shares | 70.8K | $655K | $9.24 | Sep 1, 2023 | Direct |
ONCOSEC MEDICAL Inc | Director | Common Stock | 20K | $27.4K | $1.37 | Aug 23, 2021 | Direct |
Ambrx Biopharma, Inc. | Director | Restricted Stock Units | 0 | $0 | $9.82 | Mar 7, 2024 | Direct |
Skye Bioscience, Inc. | Director | Stock Option (Right to Buy) | 35K | Feb 29, 2024 | Direct | ||
SEELOS THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 1.67K | Jan 4, 2024 | Direct |